Cite
HARVARD Citation
Bian, B. et al. (2017). Gene expression profiling of patient‐derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts. EMBO molecular medicine. 9 (4), pp. 482-497. [Online].